Antimicrobial pharmaceuticals in the aquatic environment - occurrence and environmental implications
2019/11/18 by Ewa Felis, Joanna Kalka, Adam Sochacki +5 · 28 citations
Environmental Science · Immunology and Microbiology · Biochemistry, Genetics and Molecular Biology · #Pharmaceutical and Antibiotic Environmental Impacts #Antibiotic Use and Resistance #Antibiotic Resistance in Bacteria
paper · doi:10.1016/j.ejphar.2019.172813
Abstract
The environmental occurrence of antimicrobial pharmaceuticals and antibiotic resistant bacteria and antibiotic resistant genes has become a global phenomenon and a multifaceted threat. Integrated actions of many parties are needed to prevent further aggravation of the problem. Well-directed actions require clear understanding of the problem, which can be ensured by frequent revaluation of the existing knowledge and disseminating it among relevant audiences. The goal of this review paper is to discuss the occurrence and abundance of antimicrobial pharmaceuticals in the aquatic environment in context of adverse effects caused directly by these substances and the threat associated with the antibiotics resistance phenomenon. Several classes of antimicrobial pharmaceuticals (aminoglycosides, β-lactams, glycopeptides, macrolides, fluoroquinolones, sulfonamides and trimethoprim, tetracyclines) have been selected to illustrate their sources, environmental abundance, degradation routes (transformation products) and environmental implications including their ecotoxic effect and the spread of antibiotic resistance within the compartments of the aquatic environment and wastewater treatment plants. Wastewater treatment plants are indeed the main source responsible for the prevalence of these factors in the aquatic environment, since predominantly the plants have not been designed to retain antimicrobial pharmaceuticals. In order to limit the prevalence of these impurities into the environment, better source control is recommended as well as the establishment of stricter environmental quality standards. Counteracting all the above-mentioned threats requires to undertake integrated activities based on cooperation of professionals and scientists from various fields of science or industry, such as environmental sciences, medicine, veterinary, pharmacology, chemical engineering and others.
Cited by
- Pyrolysis of pharmaceuticals as a novel means of disposal and material recovery from waste for a circular economy
- Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review
- Enhanced photoelectrocatalytic performance of direct Z-scheme CuWO4|TiO2 heterojunction for moxifloxacin oxidation
- Zinc can counteract selection for ciprofloxacin resistance. [europepmc]
- Global Evolution of Pathogenic Bacteria With Extensive Use of Fluoroquinolone Agents. [europepmc]
- Antibiotics in the environment: causes and consequences. [europepmc]
- Assessment of multiclass pharmaceutical active compounds (PhACs) in hospital WWTP influent and effluent samples by UHPLC-Orbitrap MS: Temporal variation, removals and environmental risk assessment. [europepmc]
- Graphitic Carbon Nitride: A Highly Electroactive Nanomaterial for Environmental and Clinical Sensing. [europepmc]
- High concentration and high dose of disinfectants and antibiotics used during the COVID-19 pandemic threaten human health. [europepmc]
- Evidence of Antibiotic Resistance from Population-Based Studies: A Narrative Review. [europepmc]
- Vibrio Species in an Urban Tropical Estuary: Antimicrobial Susceptibility, Interaction with Environmental Parameters, and Possible Public Health Outcomes. [europepmc]
- Pharmaceutical Pollution and Disposal of Expired, Unused, and Unwanted Medicines in the Brazilian Context. [europepmc]
- Environmental Spread of Antibiotic Resistance. [europepmc]
- Presence of Tetracycline and Sulfonamide Resistance Genes in Salmonella spp.: Literature Review. [europepmc]
- An Overview of Antibiotics as Emerging Contaminants: Occurrence in Bivalves as Biomonitoring Organisms. [europepmc]
- Performance Efficiency of Conventional Treatment Plants and Constructed Wetlands towards Reduction of Antibiotic Resistance. [europepmc]
- Prevalence and Antimicrobial Resistance of Escherichia coli , Salmonella and Vibrio Derived from Farm-Raised Red Hybrid Tilapia ( Oreochromis spp.) and Asian Sea Bass ( Lates calcarifer , Bloch 1970) on the West Coast of Peninsular Malaysia. [europepmc]
- Antibiotic Resistance in the Drinking Water: Old and New Strategies to Remove Antibiotics, Resistant Bacteria, and Resistance Genes. [europepmc]
- Enrofloxacin Induces Intestinal Microbiota-Mediated Immunosuppression in Zebrafish. [europepmc]
- Occurrence of antibiotics and bacterial resistance genes in wastewater: resistance mechanisms and antimicrobial resistance control approaches. [europepmc]
- Impact of Antibiotics as Waste, Physical, Chemical, and Enzymatical Degradation: Use of Laccases. [europepmc]
- Antibiotic resistance in aquaculture and aquatic organisms: a review of current nanotechnology applications for sustainable management. [europepmc]
- Household Pharmaceutical Waste Disposal as a Global Problem-A Review. [europepmc]
- A new family of "megaphages" abundant in the marine environment. [europepmc]
- Origin of Antibiotics and Antibiotic Resistance, and Their Impacts on Drug Development: A Narrative Review. [europepmc]
- Antibiotic Resistance in Plant Pathogenic Bacteria: Recent Data and Environmental Impact of Unchecked Use and the Potential of Biocontrol Agents as an Eco-Friendly Alternative. [europepmc]
- Environmental Antimicrobial Resistance: Implications for Food Safety and Public Health. [europepmc]
- Combatting Salmonella: a focus on antimicrobial resistance and the need for effective vaccination. [europepmc]
Related